NCT00145977View on ClinicalTrials.gov

Texture Analysis for Postmenopausal Osteoporosis

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
OsteoporosisOsteopenia
Interventions
DRUG

Alendronate

alendronate 70 mg once weekly

DIETARY_SUPPLEMENT

Calcium Citrate

600 mg of calcium citrate

DIETARY_SUPPLEMENT

Vitamin D

500 mg of Vitamin D consumed with the evening meal.

Trial Locations (1)

60637

The University of Chicago, Chicago

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

University of Chicago

OTHER

NCT00145977 - Texture Analysis for Postmenopausal Osteoporosis | Biotech Hunter | Biotech Hunter